Torrent Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	137,530	115,161	107,278	96,202	85,080
Other Revenue	2,270	-	-	-	-
Revenue	139,800	115,161	107,278	96,202	85,080
Revenue Growth (YoY)	21.39%	7.35%	11.51%	13.07%	6.29%
Cost of Revenue	33,880	27,759	26,862	27,352	24,420
Gross Profit	105,920	87,402	80,416	68,850	60,660
Selling, General & Admin	26,710	22,708	20,166	17,052	15,483
Other Operating Expenses	33,620	27,484	26,573	23,377	20,865
Operating Expenses	71,520	58,141	54,693	47,449	42,967
Operating Income	34,400	29,261	25,724	21,400	17,693
Interest Expense	-3,850	-2,514	-3,526	-3,322	-2,529
Interest & Investment Income	-	201.9	114.8	147.8	71.5
Currency Exchange Gain (Loss)	-	-166.1	-39.1	-180.8	1,695
Other Non Operating Income (Expenses)	-1,440	6.9	314.4	61.1	76
EBT Excluding Unusual Items	29,110	26,790	22,587	18,106	17,007
Merger & Restructuring Charges	-890	-	-	-	-4,847
Gain (Loss) on Sale of Investments	320	167.3	179.9	195.1	101.4
Gain (Loss) on Sale of Assets	180	13.4	-0.2	216.2	-
Asset Writedown	-	-	-129.7	-45.6	-2.3
Other Unusual Items	-	-242.1	883.8	-	-
Pretax Income	28,720	26,728	23,521	18,472	12,259
Income Tax Expense	7,340	7,616	6,957	6,019	4,487
Earnings From Continuing Operations	21,380	19,113	16,564	12,452	7,772
Minority Interest in Earnings	250	-	-	-	-
Net Income	21,630	19,113	16,564	12,452	7,772
Net Income to Common	21,630	19,113	16,564	12,452	7,772
Net Income Growth	13.17%	15.39%	33.02%	60.22%	-37.92%
Shares Outstanding (Basic)	338	338	338	338	338
Shares Outstanding (Diluted)	338	338	338	338	338
Shares Change (YoY)	-0.02%	-	-	-	-
EPS (Basic)	63.92	56.47	48.94	36.79	22.96
EPS (Diluted)	63.92	56.47	48.94	36.79	22.96
EPS Growth	13.19%	15.39%	33.02%	60.22%	-37.92%
Free Cash Flow	23,460	19,732	28,333	17,942	16,004
Free Cash Flow Per Share	69.33	58.30	83.72	53.01	47.29
Dividend Per Share	38.000	32.000	28.000	22.000	16.500
Dividend Growth	18.75%	14.29%	27.27%	33.33%	-5.71%
Gross Margin	75.77%	75.89%	74.96%	71.57%	71.30%
Operating Margin	24.61%	25.41%	23.98%	22.25%	20.80%
Profit Margin	15.47%	16.60%	15.44%	12.94%	9.13%
Free Cash Flow Margin	16.78%	17.14%	26.41%	18.65%	18.81%
EBITDA	45,590	36,758	33,249	28,026	23,823
EBITDA Margin	32.61%	31.92%	30.99%	29.13%	28.00%
D&A For EBITDA	11,190	7,498	7,526	6,626	6,130
EBIT	34,400	29,261	25,724	21,400	17,693
EBIT Margin	24.61%	25.41%	23.98%	22.25%	20.80%
Effective Tax Rate	25.56%	28.49%	29.58%	32.59%	36.60%
Revenue as Reported	138,860	115,394	107,858	96,653	87,046

Source: S&P Global Market Intelligence. Standard template. Financial Sources.